Micregen’s Board of Directors & Advisors, are composed of highly accomplished individuals with extensive and diverse experience in various fields related to business building, biotech science, and management. They bring a wealth of knowledge and expertise to the table, acquired over many years of working in academia, private and public companies. The Board member’s experience includes leading successful business ventures, working with groundbreaking regenerative biotech research and understanding the intricacies of managing complex organisations.
The Board’s collective experience and professional networks allow them to provide invaluable guidance and leadership to the company, ensuring that Micregen is well-positioned to navigate the challenges and capitalise on the opportunities in today’s rapidly changing business landscape.
Barry Sharples
Chief Executive Officer
Over the last 35 years, Barry has founded and managed several technology companies through to sale and IPO.
In 2012 he was treated as a patient at one of the founding scientist's clinics and subsequently began establishing the strategy to take this extraordinary regenerative technology to a global market before formally founding Micregen together in 2015.
Robert Mitchell, PhD
Development Director
Rob obtained his PhD at the University of Reading with his thesis specialising on the regenerative capabilities of the adult stem cell secretome, with a particular emphasis on its effect on skeletal muscle. Rob has worked with Steve and Ketan for over twelve years.Prior to working towards his PhD, Rob worked for a leading life sciences company, developing and manufacturing a wide range of reagents from their constituent materials.
Since 2019 Rob has managed and coordinated Micregen’s clinical manufacturing programme, preparing Micregen’s first therapeutic to enter a combined phase I/II clinical trial in the UK.
Steve Ray, PhD
Non-Executive Director
Former Senior Lecturer in Acute & Emergency Care at Oxford Brookes University, Professor of Neuroscience at the Carrick Institute Florida, served as International Scientific Advisor to major South African and Swiss stem cell clinics and cell banks.
Steve has extensive experience in the clinical application of stem cell secretomes that extends over twenty-five years. He has presented over one hundred papers at international scientific conferences, with nineteen as the keynote speaker. He has already translated his research through to proven clinical practice.